Imagine you’re a clinical trial manager overseeing multiple trial sites across different countries. You’re juggling participant recruitment, ensuring regulatory compliance, managing study data, coordinating site
Just imagine you’re running a multi-site clinical trial across continents. Lives are on the line, researchers are drowning in data, and sponsors are pushing for
The exciting rise of decentralized clinical trials (DCTs) has sparked interest and enthusiasm in the medical research community. These trials are changing the way medical
Source: American Pharmaceutical Review Gene therapies stand at the forefront of medical breakthroughs, promising revolutionary treatment possibilities. These therapies involve manipulating or modifying genes to
Source: Patient Worthy Challenges Unique to Cell and Gene Therapies (CGTx) Clinical Trials Cell and gene therapies (CGTx) have emerged as a novel and advanced
Source: Healthcare Business Today Cell and gene therapies (CGTx) hold immense promise as transformative treatments for a wide range of diseases. However, the successful translation
Source: SCRIP CITELINE COMMERCIAL Jeeva’s founder and CEO talks to Scrip about how the firm’s clinical trial management platform does away with the need for
Source: PRWeb Remarkable progress in the development of cell and gene therapies (CGTx) has ignited hope for millions of patients battling debilitating human diseases including Central
Source: PM360online Enhancing patient engagement in rare disease support programs requires tailored strategies that leverage innovative approaches, including AI and decentralized trials: Personalized Communication: Utilize
Source– BioProcess International The infusion of artificial intelligence (AI) technology in drug development has led to transformative solutions to age-old challenges, reshaping the trajectory from
Jeeva Clinical Trials Inc.
